Skip to content

SARS-CoV-2/Flu A&B Antigen Combo Rapid Test

by Avioq Bio-tech Co., Ltd. EUDAMED

Active European Union

Ref 40 Tests/Kit

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-06975166204330 Basic UDI-DIDate13 May 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED

Device Name
SARS-CoV-2/Flu A&B Antigen Combo Rapid Test
Model / Reference
40 Tests/Kit
Primary DI / UDI-DI
06975166204330
Basic UDI-DI
B-06975166204330
EMDN Code
W0105090601 Coronavirus / influenza - rt & poc
Device Class
Class IVD General
Market of Registration
Austria

Manufacturer details

EUDAMED SRN
CN-MF-000048146
Authorised representative
SUNGO Europe B.V. NL-AR-000000247

Other devices from Avioq Bio-tech Co., Ltd.

See all devices from Avioq Bio-tech Co., Ltd. →

Properties

Show properties
  • Reagent
  • Professional Testing
Other properties (8)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No